Aquatic Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,408
Closed -$297K 1365
2025
Q4
$297K Buy
26,408
+9,173
+53% +$105K 0.01% 893
2025
Q3
$199K Sell
17,235
-26,394
-60% -$309K ﹤0.01% 1094
2025
Q2
$534K Buy
43,629
+5,047
+13% +$63.5K 0.01% 799
2025
Q1
$553K Buy
38,582
+17,308
+81% +$270K 0.01% 742
2024
Q4
$339K Buy
21,274
+9,874
+87% +$195K 0.01% 817
2024
Q3
$274K Buy
11,400
+400
+4% +$9.14K 0.01% 761
2024
Q2
$219K Buy
+11,000
New +$214K 0.01% 731
2024
Q1
Sell
-700
Closed -$16K 1221
2023
Q4
$16K Buy
700
+600
+600% +$12.4K ﹤0.01% 1230
2023
Q3
$2K Sell
100
-6,200
-98% -$141K ﹤0.01% 1191
2023
Q2
$161K Buy
+6,300
New +$166K 0.01% 724

Other funds holding AVNS

Aquatic Capital Management's AVNS Position: Q1 2026 in Review

Aquatic Capital Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 26,408 shares — an estimated $297K sold.

Aquatic Capital Management first reported a position in AVNS in Q2 2023 and held it in 10 quarters. The position peaked at $553K in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Aquatic Capital Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 26,408 Avanos Medical shares in Q1 2026, an estimated $297K.
  • Aquatic Capital Management first reported a position in Avanos Medical in Q2 2023 and held it in 10 quarters.
  • Aquatic Capital Management's Avanos Medical position peaked at $553K in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.